Vital Farms Reports First Quarter 2026 Financial Results
First Quarter Net Revenue Grows 15.4% Versus Prior-Year Period to
Announces Plan to Wind Down Butter Business
Adjusts Fiscal Year 2026 Net Revenue Outlook to
Financial highlights for the first quarter ended
-
Net Revenue increased 15.4% to
$187.2 million , compared to$162.2 million - Gross Margin of 28.3%, compared to 38.5%
-
Net Loss of
$1.5 million , compared to Net Income of$16.9 million -
Net Loss per Diluted Share of
$0.03 , compared to Net Income per Diluted Share of$0.37 -
Adjusted EBITDA of
$5.0 million ,compared to$27.5 million 1
“Our first quarter performance fell short of expectations, as the anticipated changes in industry pricing and promotional dynamics in the outdoor access egg subcategory had a much greater impact on our velocities than we expected,” said
Additionally, following a comprehensive review process, we have made the strategic decision to wind down the butter business. This decision was driven by increased complexity in our international supply chain and more volatile economics. Exiting butter will allow us to focus on our core egg categories, where we have the greatest competitive advantages and see the strongest path to long-term value creation at this time," concluded Diez-Canseco.
1Adjusted EBITDA is a non-GAAP financial measure defined in the section titled “Non-GAAP Financial Measures” below and is reconciled to net income, its closest comparable GAAP measure, at the end of this release.
For the 13 Weeks Ended
Net revenue increased 15.4% to
Gross profit was
Loss from operations was
Net loss was
Net loss per diluted share was (
Adjusted EBITDA was
Adjusted EBITDA excludes certain non-cash items. Adjusted EBITDA is a non-GAAP financial measure defined in the section titled “Non-GAAP Financial Measures” below and is reconciled to net income, its closest comparable GAAP measure, at the end of this release.
Balance Sheet and Cash Flow Highlights
Cash, cash equivalents and marketable securities were
Capital expenditures totaled
Stock repurchased under the company’s previously announced stock repurchase program totaled 1,001,747 shares of common stock at an average price per share of
Strategic Business Update
This portfolio optimization is expected to be margin accretive upon cessation of operations, while freeing management bandwidth to accelerate distribution in the company’s core egg categories.
Fiscal 2026 Outlook
For fiscal year 2026, we expect:
-
Net revenue of
$775 million to$800 million , which represents at least 5% growth versus fiscal year 2025. This assumes that our investments in price and our distribution gains lead to a return to positive shell egg volume growth by the third quarter of 2026 with acceleration in the fourth quarter. It also assumes that competitive activity does not intensify further. -
Adjusted EBITDA of
$0 to$10 million , reflecting higher than previously anticipated promotional spending and price investments and the negative impact of approximately$32 million from costs to manage the current oversupply of eggs. -
Capital expenditures in the range of
$70 million to$75 million , compared to our previous range of$140 million to$150 million . The lower capital expenditures outlook reflects our decision to slow the pace of capital spending, particularly at VXR and new accelerator farms, to better align the timing of capacity additions with demand realization.
Vital Farms’ guidance assumes that there are no significant disruptions to the supply chain or its customers or consumers, including any issues from adverse macroeconomic factors.
Conference Call and Webcast Details
In addition,
About
Forward-Looking Statements
This press release and the earnings call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Vital Farms’ market opportunity, brand strength, anticipated growth, corporate and commercial strategy, expectations regarding tailwinds and headwinds facing Vital Farms’ industry, the impact of Vital Farms’ decision to wind down its butter business on its future operations and financial performance, including with respect to Vital Farms’ financial margins and management’s ability to accelerate distribution in the company’s core categories, the effect of prior or future expansions of Vital Farms’ processing facilities on its future revenue, the impact and expected benefits of anticipated changes in Vital Farms’ cost structure and capital expenditures, and future financial performance, including management’s outlook for fiscal year 2026 and management’s long-term outlook. These forward-looking statements are based on Vital Farms’ current assumptions, expectations, and beliefs and are subject to substantial risks, uncertainties, assumptions, and changes in circumstances that may cause Vital Farms’ actual results, performance, or achievements to differ materially from those expressed or implied in any forward-looking statement.
The risks and uncertainties referred to above include, but are not limited to: Vital Farms’ expectations regarding its revenue, expenses, and other operating results; Vital Farms’ ability to attract new consumers and customers, to successfully retain existing consumers and customers, to attract and retain its suppliers, distributors, and co-manufacturers, and to maintain its relationships with the farmers in its network and further expand its farm network, and plans for operation of accelerator farms and the impact of its decision to pause development of future accelerator farms; Vital Farms’ ability to sustain or increase its profitability; Vital Farms’ expectations regarding its future growth in the foodservice channel; Vital Farms’ ability to procure sufficient high-quality eggs and other raw materials; Vital Farms’ ability to effectively manage its supply of eggs and the impact of its current and planned supply control initiatives; real or perceived quality or food safety issues with Vital Farms’ products or other issues that adversely affect Vital Farms’ brand and reputation;
These risks and uncertainties are more fully described in Vital Farms’ filings with the Securities and Exchange Commission (SEC), including in the sections entitled “Risk Factors” in its Quarterly Report on Form 10-Q for the fiscal quarter ended
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|||||||
|
(Amounts in thousands, except share amounts) |
|||||||
|
(Unaudited) |
|||||||
|
|
13-Weeks Ended |
||||||
|
|
|
|
|
||||
|
Net revenue |
$ |
187,155 |
|
|
$ |
162,189 |
|
|
Cost of goods sold |
|
134,146 |
|
|
|
99,676 |
|
|
Gross profit |
|
53,009 |
|
|
|
62,513 |
|
|
Operating expenses: |
|
|
|
|
|
||
|
Selling, general and administrative |
|
44,364 |
|
|
|
31,909 |
|
|
Shipping and distribution |
|
10,977 |
|
|
|
8,835 |
|
|
Total operating expenses |
|
55,341 |
|
|
|
40,744 |
|
|
(Loss) income from operations |
|
(2,332 |
) |
|
|
21,769 |
|
|
Other income (expense), net: |
|
|
|
|
|
||
|
Interest expense |
|
(190 |
) |
|
|
(234 |
) |
|
Interest income |
|
772 |
|
|
|
1,211 |
|
|
Other expense, net |
|
(109 |
) |
|
|
(404 |
) |
|
Total other income, net |
|
473 |
|
|
|
573 |
|
|
Net (loss) income before income taxes |
|
(1,859 |
) |
|
|
22,342 |
|
|
Income tax (benefit) provision |
|
(337 |
) |
|
|
5,441 |
|
|
Net (loss) income |
$ |
(1,522 |
) |
|
$ |
16,901 |
|
|
Net (loss) income per share: |
|
|
|
|
|
||
|
Basic: |
$ |
(0.03 |
) |
|
$ |
0.38 |
|
|
Diluted: |
$ |
(0.03 |
) |
|
$ |
0.37 |
|
|
Weighted average common shares outstanding: |
|
|
|
|
|
||
|
Basic: |
|
44,587,704 |
|
|
|
44,250,685 |
|
|
Diluted: |
|
44,587,704 |
|
|
|
45,804,924 |
|
|
|
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
|
(Amounts in thousands, except share amounts) |
|||||||
|
|
|
|
|
||||
|
|
(Unaudited) |
|
|
|
|||
|
Assets |
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
||
|
Cash and cash equivalents |
$ |
36,625 |
|
|
$ |
48,831 |
|
|
Investment securities, available-for-sale |
|
14,807 |
|
|
|
64,520 |
|
|
Accounts receivable, net of allowance for credit losses of |
|
51,427 |
|
|
|
67,849 |
|
|
Inventories |
|
90,216 |
|
|
|
66,495 |
|
|
Prepaid expenses and other current assets, net of allowance for credit losses of |
|
12,423 |
|
|
|
11,304 |
|
|
Income taxes receivable |
|
1,537 |
|
|
|
1,410 |
|
|
Assets held for sale |
|
2,141 |
|
|
|
2,141 |
|
|
Total current assets |
|
209,176 |
|
|
|
262,550 |
|
|
Property, plant and equipment, net |
|
177,914 |
|
|
|
160,601 |
|
|
Operating lease right-of-use assets |
|
90,086 |
|
|
|
80,390 |
|
|
|
|
15,468 |
|
|
|
15,197 |
|
|
Total assets |
$ |
492,644 |
|
|
$ |
518,738 |
|
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
|
||
|
Accounts payable |
$ |
54,595 |
|
|
$ |
55,141 |
|
|
Accrued liabilities |
|
49,140 |
|
|
|
54,826 |
|
|
Operating lease liabilities, current |
|
7,703 |
|
|
|
4,673 |
|
|
Finance lease liabilities, current |
|
5,780 |
|
|
|
5,670 |
|
|
Income taxes payable |
|
1,202 |
|
|
|
1,268 |
|
|
Total current liabilities |
|
118,420 |
|
|
|
121,578 |
|
|
Operating lease liabilities, non-current |
|
37,146 |
|
|
|
38,050 |
|
|
Finance lease liabilities, non-current |
|
3,607 |
|
|
|
5,098 |
|
|
Other liabilities |
|
2,563 |
|
|
|
2,752 |
|
|
Total liabilities |
$ |
161,736 |
|
|
$ |
167,478 |
|
|
Commitments and contingencies |
|
|
|
|
|
||
|
Stockholders’ equity: |
|
|
|
|
|
||
|
Preferred stock, |
|
— |
|
|
|
— |
|
|
Common stock, |
|
4 |
|
|
|
4 |
|
|
Additional paid-in capital |
|
183,029 |
|
|
|
201,820 |
|
|
Retained earnings |
|
147,873 |
|
|
|
149,395 |
|
|
Accumulated other comprehensive income |
|
2 |
|
|
|
41 |
|
|
Total stockholders’ equity |
$ |
330,908 |
|
|
$ |
351,260 |
|
|
Total liabilities and stockholders’ equity |
$ |
492,644 |
|
|
$ |
518,738 |
|
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
(Amounts in thousands) |
|||||||
|
(Unaudited) |
|||||||
|
|
13-Weeks Ended |
||||||
|
|
|
|
|
||||
|
Cash flows from operating activities: |
|
|
|
|
|
||
|
Net (loss) income |
$ |
(1,522 |
) |
|
$ |
16,901 |
|
|
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: |
|
|
|
|
|
||
|
Depreciation and amortization |
|
3,959 |
|
|
|
3,259 |
|
|
Reduction in the carrying amount of right-of-use assets |
|
3,381 |
|
|
|
1,687 |
|
|
Stock-based compensation expense |
|
2,756 |
|
|
|
2,853 |
|
|
Increase (decrease) in inventory provision |
|
709 |
|
|
|
(15 |
) |
|
Amortization of capitalized cloud computing arrangement costs |
|
744 |
|
|
|
— |
|
|
Amortization and accretion of available-for-sale securities |
|
(490 |
) |
|
|
12 |
|
|
Amortization of debt issuance costs |
|
21 |
|
|
|
22 |
|
|
Uncertain tax positions |
|
(188 |
) |
|
|
— |
|
|
Deferred taxes |
|
7 |
|
|
|
240 |
|
|
Net realized losses on derivative instruments |
|
118 |
|
|
|
432 |
|
|
Other |
|
761 |
|
|
|
(196 |
) |
|
Net change in operating assets and liabilities |
|
(28,811 |
) |
|
|
(19,921 |
) |
|
Net cash (used in) provided by operating activities |
$ |
(18,555 |
) |
|
$ |
5,274 |
|
|
Cash flows from investing activities: |
|
|
|
|
|
||
|
Purchases of property, plant and equipment |
|
(20,756 |
) |
|
|
(3,127 |
) |
|
Proceeds from the sale of available-for-sale securities |
|
28,157 |
|
|
|
404 |
|
|
Maturities of available-for-sale securities |
|
22,000 |
|
|
|
4,275 |
|
|
Purchases of derivative instruments |
|
(261 |
) |
|
|
— |
|
|
Proceeds from the settlement of derivative instruments |
|
137 |
|
|
|
— |
|
|
Proceeds from the sale of property, plant and equipment |
|
— |
|
|
|
48 |
|
|
Net cash provided by investing activities |
$ |
29,277 |
|
|
$ |
1,600 |
|
|
Cash flows from financing activities: |
|
|
|
|
|
||
|
Proceeds from exercise of stock options |
|
— |
|
|
|
2,715 |
|
|
Repurchases of common stock |
|
(20,000 |
) |
|
|
— |
|
|
Payment of tax withholding obligation on vested restricted stock unit shares |
|
(1,547 |
) |
|
|
(2,882 |
) |
|
Principal payments under finance lease obligations |
|
(1,381 |
) |
|
|
(1,003 |
) |
|
Net cash used in financing activities |
$ |
(22,928 |
) |
|
$ |
(1,170 |
) |
|
Net (decrease) increase in cash and cash equivalents |
|
(12,206 |
) |
|
|
5,704 |
|
|
Cash and cash equivalents at beginning of the period |
|
48,831 |
|
|
|
150,601 |
|
|
Cash and cash equivalents at end of the period |
$ |
36,625 |
|
|
$ |
156,305 |
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
||
|
Cash paid for interest |
$ |
169 |
|
|
$ |
212 |
|
|
Cash paid for income taxes, net of amounts refunded |
|
39 |
|
|
|
3 |
|
|
Supplemental disclosure of non-cash investing and financing activities: |
|
|
|
|
|
||
|
Purchases of property, plant and equipment included in accounts payable and accrued liabilities |
$ |
10,657 |
|
|
$ |
522 |
|
Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, management believes that Adjusted EBITDA and Adjusted EBITDA Margin, non-GAAP financial measures, provide investors with additional useful information in evaluating our performance.
Adjusted EBITDA and Adjusted EBITDA Margin are financial measures that are not required by or presented in accordance with GAAP. We believe that Adjusted EBITDA and Adjusted EBITDA Margin, when taken together with our financial results presented in accordance with GAAP, provide meaningful supplemental information regarding our operating performance and facilitate internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA and Adjusted EBITDA Margin are helpful to our investors as they are measures used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes. We calculate Adjusted EBITDA as net (loss) income, adjusted to exclude: (1) depreciation and amortization; (2) stock-based compensation expense; (3) (benefit) or provision for income taxes as applicable; (4) interest expense; (5) interest income; and (6) amortization of cloud computing arrangements. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by net revenue.
Adjusted EBITDA and Adjusted EBITDA Margin are presented for supplemental informational purposes only, have limitations as analytical tools and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA and Adjusted EBITDA Margin include that (1) they do not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA and Adjusted EBITDA Margin do not reflect these capital expenditures, (3) they do not consider the impact of stock-based compensation expense, (4) they do not reflect other non-operating expenses, including interest expense; and (5) they do not reflect tax payments that may represent a reduction in cash available to us. In addition, our use of Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA and Adjusted EBITDA Margin in the same manner, limiting the usefulness as comparative measures. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA and Adjusted EBITDA Margin alongside other financial measures, including our net (loss) income, net (loss) income margin and other results stated in accordance with GAAP.
|
|
||||||||
|
ADJUSTED EBITDA RECONCILIATION |
||||||||
|
(Amounts in thousands) |
||||||||
|
(Unaudited) |
||||||||
|
|
|
13-Weeks Ended |
||||||
|
|
|
|
|
|
||||
|
|
|
(in thousands) |
||||||
|
Net (loss) income |
|
$ |
(1,522 |
) |
|
$ |
16,901 |
|
|
Depreciation and amortization1 |
|
|
3,959 |
|
|
|
3,259 |
|
|
Stock-based compensation expense |
|
|
2,756 |
|
|
|
2,853 |
|
|
Income tax (benefit) provision |
|
|
(337 |
) |
|
|
5,441 |
|
|
Interest expense |
|
|
190 |
|
|
|
234 |
|
|
Interest income |
|
|
(772 |
) |
|
|
(1,211 |
) |
|
Amortization of cloud computing arrangements |
|
|
744 |
|
|
|
— |
|
|
Adjusted EBITDA |
|
$ |
5,018 |
|
|
$ |
27,477 |
|
|
|
|
|
|
|
|
|
||
|
Net revenue |
|
$ |
187,155 |
|
|
$ |
162,189 |
|
|
Net (loss) income margin2 |
|
|
(0.8 |
%) |
|
|
10.4 |
% |
|
Adjusted EBITDA Margin3 |
|
|
2.7 |
% |
|
|
16.9 |
% |
|
(1) Amount also includes finance lease amortization. |
||||||||
| (2) Net income margin is calculated by dividing net income by net revenue. | ||||||||
| (3) Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by net revenue. | ||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260507425592/en/
Media:
Rob.Discher@vitalfarms.com
Investors:
Brian.Shipman@vitalfarms.com
Source: